Trevi Therapeutics Inc
NASDAQ:TRVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Trevi Therapeutics Inc
NASDAQ:TRVI
|
US |
|
G
|
Golden Star Enterprises Ltd
OTC:GSPT
|
US |
|
N
|
NextGen Healthcare Inc
F:QY1
|
US |
|
Sodexo SA
PAR:SW
|
FR |
|
IFAN Financial Inc
OTC:IFAN
|
US |
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
Source Energy Services Ltd
TSX:SHLE
|
CA |
|
James Cropper PLC
LSE:CRPR
|
UK |
|
D
|
Dynamic Technologies Group Inc
XTSX:DTG
|
CA |
|
S
|
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
|
CN |
|
Bluerock Residential Growth REIT Inc
F:BKO
|
US |
|
A
|
Abhinav Leasing & Finance Ltd
BSE:538952
|
IN |
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
C
|
Cartesian Growth Corporation II
NASDAQ:RENE
|
US |
Wall Street
Price Targets
TRVI Price Targets Summary
Trevi Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TRVI
is 21.93 USD
with a low forecast of 16.16 USD and a high forecast of 28.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TRVI's stock price target?
Price Target
21.93
USD
According to Wall Street analysts, the average 1-year price target for
TRVI
is 21.93 USD
with a low forecast of 16.16 USD and a high forecast of 28.35 USD.